Thermage and Reliant Technologies to J... (is press release will be presented in fu...)

Thermage and Reliant Technologies to Join Forces

Date:7/7/2008

is press release will be presented in future public filings. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made. Thermage undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events.

Additional Information and Where You Can Find It

This communication may be deemed solicitation material in respect of the proposed transaction between Thermage and Reliant. In connection with the transaction, Thermage will file a registration statement on Form S-4 with the SEC containing a proxy statement/prospectus. The proxy statement/prospectus will be mailed to the stockholders of Thermage. Investors and security holders of Thermage are urged to read the proxy statement/prospectus when it becomes available because it will contain important information about Thermage and the proposed transaction. The proxy statement/prospectus (when it becomes available), and any other documents filed by Thermage with the SEC, may be obtained free of charge at the SEC's web site at http://www.sec.gov. In addition, investors and security holders may obtain free copies of the documents filed with the SEC by Thermage by contacting Thermage Investor Relations by e-mail at IR@thermage.com or by telephone at (510) 259-7117. Investors and security holders are urged to read the proxy statement/prospectus and the other relevant materials when they become available before making any voting or investment decision with respect to the proposed transaction.

Thermage and its respective directors and executive officers may be deemed to be participants in the solicitation of proxies from its stockholders in favor of the proposed transaction. Information about the directors and executive officers of Thermage and their respective interests in
'/>"/>

SOURCE Thermage, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7
Related medicine news :

1. Thermage, Inc. to Present at the Maxim Group Growth Conference
2. Thermage, Inc. Announces Distribution Agreement With Eclipse Medical, Ltd.
3. Thermage Announces Third Quarter Financial Results
4. Thermage, Inc. Appoints John F. Glenn as Chief Financial Officer
5. Thermage, Inc. Announces Fourth Quarter 2007 Results Release Date and Conference Call
6. Thermage Announces Fourth Quarter and Full Year 2007 Financial Results
7. Thermage, Inc. Announces Initial Shipments of Cellulite Product
8. Thermage, Inc. Announces First Quarter 2008 Results Release Date and Conference Call
9. Thermage, a Leading Aesthetic Medical Device Company, Announces First Time Exhibitor Status at ACOG Meeting
10. Thermage, Inc. to Present at the Bank of America 2008 Healthcare Conference
11. Reliant Energy, Houston Texans Ahman Green and Matt Schaub Team to Hold News Conference, Book Signing to Raise Awareness about Autism

Post Your Comments:

(Date:5/23/2013)... have shown that an immune regulatory molecule called IL-21 ... viral infections. , The results are published in the ... how IL-21 could be important in the development of ... PhD, the first author of the paper. The senior ... Vaccine Center and a Georgia Research Alliance Eminent Scholar. ...

(Date:5/23/2013)... Netsmart today announced it is ranked ... information technology (HIT) providers for 2013. , The HCI 100 ... Healthcare Informatics magazine. Netsmart’s ranking of #49 is up ... growth is largely due to our commitment to helping organizations ... where resources are scarce, the demand for care is unprecedented ...

(Date:5/23/2013)... patients over the past two decades have found ... of new therapies, overall mortality has decreased and ... of severe abnormal heart rhythms, has declined. ... today, with these significant improvements, one-third of patients ... diagnosed with advanced disease. Heart failure is increasingly ...

(Date:5/23/2013)... (PRWEB) May 23, 2013 Elegance for a woman ... her flair, her taste, her intrigue can often be found in ... gateway to a woman's soul is through her eyes. It ... who she is! That is why the elegance of a woman ... . , Women today, more than any other time, utilize eyewear ...

(Date:5/23/2013)... 2013 A new report ... Medicaid program could save $2.1 billion without reducing access ... report shows that Florida and other state Medicaid programs ... and employers rely on to curb wasteful pharmacy spending. ... pharmacy at MedicaidPharmacySavings.com . , “The easiest way ...

Breaking Medicine News(10 mins):Health News:Vaccine blackjack: IL-21 critical to fight against viral infections 2 Health News:Netsmart Named to Healthcare Informatics Top 100 List 2 Health News:Death rates decline for advanced heart failure patients, but outcomes are still not ideal 2 Health News:Death rates decline for advanced heart failure patients, but outcomes are still not ideal 3 Health News:Dolabany Eyewear Adds Feminine Flare to Women's Designer Eyewear with 2013 New Release of Adelina by Best Image Optical, Inc. 2 Health News:PCMA: Upgrading Medicaid Drug Benefits Could Save Florida $2.1 Billion 2

[0] Vaccine blackjack: IL-21 critical to fight against viral infections [0] Netsmart Named to Healthcare Informatics Top 100 List [0] Death rates decline for advanced heart failure patients, but outcomes are still not ideal [0] Dolabany Eyewear Adds Feminine Flare to Women's Designer Eyewear with 2013 New Release of Adelina by Best Image Optical, Inc.[0] PCMA: Upgrading Medicaid Drug Benefits Could Save Florida $2.1 Billion

... Eating Tips to Stay Balanced Through the ... ... Registered dietitian, celebrity,chef, and New York Times best-selling author Ellie Krieger, ... the benefits of,digestive health. Yo-Plus contains live and active probiotic cultures,specifically ...

... N.C., Nov. 5 Cornerstone Therapeutics,Inc. (Nasdaq ... on,developing and commercializing prescription medications for respiratory,disorders, ... of the recently,completed merger between Cornerstone BioPharma ... Collard, 42, president and chief executive,officer and ...

... 5 CardiacAssist, Inc. announced that,it reached a new high ... least one TandemHeart case during the third quarter of 2008.,In ... on,year growth in case activity with a leap of 64 ... and 497 %. Through nine months of 2008,CardiacAssist has also ...

... Corporate Highlights:, -- Net service revenues increased 84% to $58.7 ... to $48.6 million -- Net income increased 149% to $4.7 ... share on 49% more shares -- Completed acquisition of Patient ... 200 Best Small Companies List, Almost Family, Inc. (Nasdaq: ...

... to ... 9-hour flights, HOBOKEN, N.J., Nov. 5 ... pine bark,extract from the French maritime pine tree, reduces jetlag in passengers ... and a,scoring system, showed Pycnogenol(R) lowered symptoms of jetlag such as,fatigue, headaches, ...

... Nov. 5 CuraGen Corporation,(Nasdaq: CRGN ), a ... Timothy M. Shannon, President and Chief,Executive Officer, will present ... Investment Conference on Wednesday, November 12, 2008, at,3:15 p.m. ... New York Palace,Hotel in New York, NY., Access ...

Healthy Eating Expert Ellie Krieger Joins Yoplait(R) Yo-Plus(TM) to Raise Awareness of Digestive Health Cornerstone Therapeutics Announces New Board of Directors CardiacAssist, Inc. Announces Record Breaking Site Activity and Financial Results Almost Family Reports Third Quarter 2008 Results Study Shows Pine Bark Reduces Jetlag CuraGen to Present at the Rodman & Renshaw Annual Global Investment Conference

(Date:5/23/2013)... , May 23, 2013 MedVantx, Inc., the ... pharmaceutical distribution channel announced today the Company has completed ... manage $1.5B in pharmaceutical products and the upgrade of ... to cGMP facilities in its specialty home delivery pharmacy ... Company provides leading pharmaceutical manufacturers, physicians, health systems and ...

(Date:5/23/2013)... InspireMD, Inc. ("InspireMD" or ... embolic protection stents, today announced new 6-month results ... Reperfusion) trial demonstrating that the MGuard Embolic Protection ... stents in all-cause mortality in ST segment elevation ... were presented at the InspireMD STEMI Symposium at ...

(Date:5/23/2013)... Nederland keurt als eerste nieuwe ... met BPH Astellas Pharma EUROPE ... Inc, gebaseerd in Tokyo ( ... het Nederlandse College ter Beoordeling van Geneesmiddelen (CBG) een ... De handelsvergunning verleend voor VESOMNI is voor "de behandeling ...

Breaking Medicine Technology:MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 2 MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 3 InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 2 InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 3 InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 4 InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 5 Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 2 Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 3 Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 4

[0] MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy [0] InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group [0] Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen

... Phase II Testing Certification with Edifecs CORE Testing Service ... in X12 Version 5010BELLEVUE, Wash., April 5 ... its partners CAQH and Harvard Pilgrim Health Care, examine ... II Certification testing including elements of the newly mandated ...

... SILVER SPRING, Md., April 2 Novo Nordisk today announced ... United States Food and Drug Administration (FDA) has finalized its ... analogue. The Advisory Committee voted on questions related to the ... , A majority ...

Cached Medicine Technology:Edifecs, CAQH and Harvard Pilgrim Health Care Will Examine CORE Phase II Testing Outcomes and Lessons Learned at HIMSS09 Interoperability Showcase 2 Edifecs, CAQH and Harvard Pilgrim Health Care Will Examine CORE Phase II Testing Outcomes and Lessons Learned at HIMSS09 Interoperability Showcase 3 Edifecs, CAQH and Harvard Pilgrim Health Care Will Examine CORE Phase II Testing Outcomes and Lessons Learned at HIMSS09 Interoperability Showcase 4 Edifecs, CAQH and Harvard Pilgrim Health Care Will Examine CORE Phase II Testing Outcomes and Lessons Learned at HIMSS09 Interoperability Showcase 5 Update on FDA Advisory Committee Meeting on Liraglutide for the Treatment of Type 2 Diabetes 2 Update on FDA Advisory Committee Meeting on Liraglutide for the Treatment of Type 2 Diabetes 3

Edifecs, CAQH and Harvard Pilgrim Health Care Will Examine CORE Phase II Testing Outcomes and Lessons Learned at HIMSS09 Interoperability Showcase Update on FDA Advisory Committee Meeting on Liraglutide for the Treatment of Type 2 Diabetes

Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • With Tubular Base....

Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • With casters • With Tubular Base....

... an independent laboratory to ... of Federal Standard 209E. ... confort, reduces fatique and ... meets Class 100 particle ...

Medicine Products:

4V62 4V42-R 4V41-R Class 100 Chair